Cognition Therapeutics

Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
CP Wire
Tue, 05/22/18 - 06:17 pm
Cognition Therapeutics
Elayta
NIH
grants
Alzheimer's disease
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
Tue, 05/22/18 - 06:16 pm
Cognition Therapeutics
Alzheimer's disease